As a biopharmaceutical manufacturer, you would like to carry out an analysis of peptide aggregation
What is a peptide aggregation?
A peptide aggregation is an assembly of several peptide molecules that group together spontaneously or under certain environmental conditions. These aggregates can be reversible (if the peptides can dissociate) or irreversible (stable formation of insoluble aggregates).
How a peptide aggregation is formed
This phenomenon can be due to various molecular interactions, such as hydrogen bonds, Van der Waals forces or hydrophobic interactions. Aggregate formation is a major issue in the pharmaceutical and biotechnology industry, as it can affect the stability, efficacy and safety of peptide formulations, including by increasing the risk of immunogenicity.
Peptide aggregation analysis is therefore crucial to optimize manufacturing processes, ensure product quality and meet regulatory requirements.
Why analyze peptide aggregation?
Peptide aggregation analysis is essential to:
- Ensure the stability of biopharmaceutical formulations
- Comply with the regulatory requirements of health authorities
- Anticipate immunogenicity risks related to aggregations
- Optimize formulation and production processes
FILAB supports biopharmaceutical manufacturers in the analysis of peptide aggregation
Why choose FILAB?
FILAB laboratory, analytical expertise laboratory, offers analysis services for your peptide aggregations using cutting-edge techniques adapted to industrial constraints and regulatory requirements.
Our experts support you in interpreting the results and optimizing your formulations. Thanks to our expertise in analysis, expertise and R&D, we help you solve your specific problems and guarantee the quality of your products.
Our analysis services
Identification and fine characterization of glycosylated structures
Complementary structural characterization
Characterization of therapeutic glycoproteins, biosimilars and vaccines.
Separation and analysis of derivatized glycans
